Showing 2121-2130 of 2711 results for "".
- Breaking Business News: Apax Partners to Acquire Syneronhttps://modernaesthetics.com/news/breaking-business-news-apax-partner-to-acquire-syneron/2472253/An affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron Candela for $11.00 per share in cash in a transaction valued at approximately $397 million. The per share acquisition price represe
- Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Foldshttps://modernaesthetics.com/news/juvderm-vollure-xc-fda-approved-for-correction-of-facial-wrinkles-and-folds/2472255/The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US pivotal clinical trial, a majority (59 percent) of subjects saw improvement in moderate to severe na
- ASAPS: Americans Spent Big on Cosmetic Surgery in 2016https://modernaesthetics.com/news/asaps-americans-spent-big-on-cosmetic-surgery-in-2016/2472257/15 + B That’s the amount of money that Americans doled out for cosmetic surgery in 2016, according to newly released statistics from the American Society for Aesthetic Plastic Surgery (ASAPS). That’s 1.5 B more then they spe
- Zeltiq Showcases CoolAdvantage Petite Applicator at AAD Annual Meetinghttps://modernaesthetics.com/news/zeltiq-showcases-cooladvantage-petite-applicator-at-aad-annual-meeting/2472261/ZELTIQ® Aesthetics is showcasing the CoolAdvantage Petite™ applicator at the American Academy of Dermatology Annual Meeting (AAD) in Orlando. The CoolAdvantage technology is the only non-invasive fat removal technology cleared by the
- ASAPS 2016: Labiaplasty More Than A Fadhttps://modernaesthetics.com/news/asaps-2016-labiaplasty-more-than-a-fad/2472263/When it rains, it pours. Both the American Society of Plastic Surgeons (ASPS) and sister organization American Society for Aesthetic Plastic Surgery (ASAPS) released some (ASAPS) or all (ASPS) of their annual statistics. And by and
- BTL Aesthetics Unveils New Ultra Femme 360° Technology for Vaginal Rejuvenationhttps://modernaesthetics.com/news/btl-aesthetics-unveils-new-ultra-femme-360-technology-for-vaginal-rejuvenation/2472265/BTL Industries is introducing its new 360° technology to leading cosmetic dermatologists and physicians during the annual American Academy of Dermatology (AAD) Conference taking place in Orlando, FL, March 3rd – 7th, with th
- ASPS 2016 Stats: Cosmetic Surgery On The Risehttps://modernaesthetics.com/news/asps-2016-stats-cosmetic-surgery-on-the-rise/2472267/Fat is still phat – at least in some places like the breasts, butt and face, according to the annual statistics from the American Society of Plastic Surgeons (ASPS). Specifically, minimally invasive cosmetic fat injections incre
- Cynosure to Be Acquired by Hologichttps://modernaesthetics.com/news/cynosure-to-be-acquired-by-hologic/2472278/Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d